Evidence map›Paper›PMID 31684048›Full record

ArticleJournal of cardiovascular development and disease2019

Krox20 Regulates Endothelial Nitric Oxide Signaling in Aortic Valve Development and Disease.

Gaëlle Odelin, Emilie Faure, Corinne Maurel-Zaffran, Stéphane Zaffran

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. New Concepts in the Development and Malformation of the Arterial Valves.Journal of cardiovascular development and disease · 2020
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gaëlle OdelinAix Marseille University, INSERM, Marseille Medical Genetics, U1251, 13005 Marseille, France. gaelle.odelin@univ-amu.fr.ORCID 0000-0002-1395-7114
Emilie FaureAix Marseille University, INSERM, Marseille Medical Genetics, U1251, 13005 Marseille, France. emilie.faure@univ-amu.fr.ORCID 0000-0002-0568-1381
Corinne Maurel-ZaffranAix Marseille University, CNRS UMR7288, IBDM, 13009 Marseille, France. corinne.maurel-zaffran@univ-amu.fr.
Stéphane ZaffranAix Marseille University, INSERM, Marseille Medical Genetics, U1251, 13005 Marseille, France. stephane.zaffran@univ-amu.fr.
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

AFM-Téléthon NMH-DecryptFondation Lefoulon Delalande fellowshipFondation pour la Recherche Médicale DPC20111123002Institut National de la Santé et de la Recherche Médicale #
6 · The paper itself

Abstract

Among the aortic valve diseases, the bicuspid aortic valve (BAV) occurs when the aortic valve has two leaflets (cusps), rather than three, and represents the most common form of congenital cardiac malformation, affecting 1-2% of the population. Despite recent advances, the etiology of BAV is poorly understood. We have recently shown that

Indexed as

bicuspid aortic valvecardiac developmentheartKrox20mousenitric oxide synthase

Identifiers

PMID31684048
PMCPMC6955692
OpenAlexW2989404679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.